Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Gets $1.2M From NCI to Build Protein Immunoassay Platform

NEW YORK, March 12 - Illumina will be getting $1.2 million from the National Cancer Institute to develop a multiplexed immunoassay system for proteins and post-translational protein modifications, the company said.

 

Illumina will design the system for use in identifying and exploring defects in the homeostasis of the lymphoid system, and the immune response to cancer.

 

The grant is a Phase 2 research grants funded through NCI's Innovative Molecular Analysis Technologies program. It will help the company adapt its microbead array technology, now used for DNA and RNA analysis, in order to measure and characterize proteins.

 

The company will partner with Christopher Goodnow, who is professor of molecular medicine at the Australian National University's John Curtin School for Medical Research. Goodnow's research centers on investigating lymphocyte reactions in order to understand autoimmune disorders, allergies, metastatic cancers, and diseases like leukemia and lymphoma.

He has previously worked with Illumina on a project to use arrays in order to investigate gene expression and protein activity in mutant mice.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.